J. A. Steiner

950 citations

23 papers · 749 indexed · h-index 11

Co-authors: Roy Pettipher Mark A. Payton L. Pearce Collins Michael Hunter Toby C. Lewis Christopher Perkins W. J. Jenkins John I. Bell
Topics: Receptor Mechanisms and Signaling (3 papers)Asthma and respiratory diseases (3 papers)Analytical Methods in Pharmaceuticals (3 papers)
Cited by: Immunology and Allergy Physiology Rheumatology
Journals: Journal of Clinical Oncology Annals of Oncology Psychopharmacology
Partner nations: United Kingdom Switzerland Australia

In The Last Decade

J. A. Steiner

21 papers receiving 706 citations

Peers

Countries citing papers authored by J. A. Steiner

Since Specialization

Citations

This map shows the geographic impact of J. A. Steiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. A. Steiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. A. Steiner more than expected).

Fields of papers citing papers by J. A. Steiner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. A. Steiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. A. Steiner. The network helps show where J. A. Steiner may publish in the future.

Co-authorship network of co-authors of J. A. Steiner

This figure shows the co-authorship network connecting the top 25 collaborators of J. A. Steiner. A scholar is included among the top collaborators of J. A. Steiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. A. Steiner. J. A. Steiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation and testing of polymethylmetacrylic (PMMA) bone cements with admixed Amphotericin B 2025 ·Journal of Orthopaedic Surgery and Research ·(unknown),(unknown),J. A. Steiner,(unknown),Mario Morgenstern,Martin Clauss,Klaus‐Dieter Kühn	1
2	Voriconazole Admixed with PMMA—Impact on Mechanical Properties and Efficacy 2023 ·Antibiotics ·(unknown),J. A. Steiner,Andrej Trampuž,Klaus‐Dieter Kühn	10
3	Interim results from the completed first-in-human phase I dose escalation study evaluating MP0250, a multi-DARPin® blocking HGF and VEGF, in patients with advanced solid tumors 2016 ·Annals of Oncology ·Mark R. Middleton,(unknown),Sanjeev Kumar,(unknown),Jordi Rodón,Karin H. Herbschleb,J. A. Steiner,Christof Zitt,Daniel Feurstein,Sabrina Schreiner,(unknown),Keith M. Dawson,(unknown),(unknown),Michael T. Stumpp,A. Harstrick,Richard D. Baird,Aurelius Omlin	4
4	Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459 2014 ·Allergy ·Roy Pettipher,Michael Hunter,Christopher Perkins,L. Pearce Collins,Toby C. Lewis,M Baillet,J. A. Steiner,John I. Bell,Mark A. Payton	103
5	Anti‐eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis 2013 ·Allergy ·Alex Straumann,(unknown),(unknown),(unknown),(unknown),L. Pearce Collins,Mark A. Payton,Roy Pettipher,Michael Hunter,J. A. Steiner,Hans‐Uwe Simon	161
6	The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo‐controlled, double‐blind trial 2012 ·Allergy ·Friedrich Horak,Petra Zieglmayer,René Zieglmayer,Patrick Lemell,L. Pearce Collins,Michael Hunter,J. A. Steiner,Toby C. Lewis,Mark A. Payton,Christopher Perkins,Roy Pettipher	74
7	A randomized, double‐blind, placebo‐controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma 2011 ·Clinical & Experimental Allergy ·N. Barnes,Ian Pavord,А. Г. Чучалин,John I. Bell,(unknown),Toby C. Lewis,Debbie Parker,Mark A. Payton,L. Pearce Collins,Roy Pettipher,J. A. Steiner,Christopher Perkins	175
8	Results of a phase I/II clinical trial with OncoVEX^GM-CSF, a second generation oncolytic herpes simplex virus 2005 ·Journal of Clinical Oncology ·R. S. Coffin,(unknown),(unknown),Nicholas D. James,Colin Love,Agnieszka Michael,H. Pandha,J. A. Steiner,Neil Steven,R. Charles Coombes	4
9	A semi-quantitative survey of older adults to assess barriers to participation in early phase clinical trials (EPCTs) 2005 ·Journal of Clinical Oncology ·M. Basche,Alan Baron,S. Gail Eckhardt,(unknown),Neil D. Jackson,(unknown),Amy Levin,J. A. Steiner	0
10	Initial and Steady State Pharmacokinetics of Cilazapril in Congestive Cardiac Failure 1991 ·Journal of Pharmacy and Pharmacology ·(unknown),(unknown),Robert J. Francis,AN Brown,(unknown),J. A. Steiner,D S Dymond	3
11	An assessment of tenoxicam, a nonsteroidal anti-inflammatory drug of long half-life, in patients with impaired renal function suffering from osteoarthritis or rheumatoid arthritis 1989 ·Clinical Rheumatology ·H. A. Bird,Alison Clarke,P D Fowler,(unknown),(unknown),J. A. Steiner	8
12	A pharmacokinetic study of cilazapril in patients with congestive heart failure. 1989 ·British Journal of Clinical Pharmacology ·Éric Rosenthal,(unknown),AN Brown,(unknown),(unknown),J. A. Steiner,(unknown)	12
13	Disposition of bemitradine, a Renal Vasodilator and Diuretic, in Man 1988 ·Xenobiotica ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),J. A. Steiner	2
14	Single- and multiple-dose pharmacokinetics of nufenoxole in healthy human subjects 1987 ·Xenobiotica ·(unknown),(unknown),(unknown),J. A. Steiner,(unknown),(unknown),(unknown),(unknown)	1
15	The Prevalence of Sexual Dysfunction in Male and Female Hypertensive Patients 1987 ·Sexual and Marital Therapy ·Alan Riley,J. A. Steiner,Rosalin Cooper,(unknown)	15
16	Efficacy of clonidine in treatment of alcohol withdrawal state 1983 ·Psychopharmacology ·(unknown),W. J. Jenkins,J. A. Steiner	81
17	Central pharmacological control of corticosterone secretion in the intact rat. demonstration of cholinergic and serotoninergic facilitatory and ?-adrenergic inhibitory mechanisms 1980 ·Psychopharmacology ·J. A. Steiner,A. David Smith	28
18	A double blind factorial trial of pindolol and hydrochlorothiazide in hypertension 1975 ·Clinical and Experimental Pharmacology and Physiology ·A. J. C. Bune,John Chalmers,PI Korner,J. A. Steiner,(unknown),(unknown),Michael L. West,(unknown)	5
19	A Comparison of Propranolol and Compound R03-4787 in the Treatment of Arterial Hypertension in Man 1974 ·Clinical Science ·C F George,Penny Lewis,J. A. Steiner,C. T. Dollery	4
20	L–DOPA AND THE SHY–DRAGER SYNDROME ^* 1974 ·The Medical Journal of Australia ·J. A. Steiner,Phillip A. Low,C. Y. Huang,Malcolm West,John B. Uther,(unknown),John Chalmers	10

About J. A. Steiner

J. A. Steiner is a scholar working on Biological Psychiatry, Analytical Chemistry and Behavioral Neuroscience, having authored 23 papers that have together received 749 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (3 papers), Asthma and respiratory diseases (3 papers) and Analytical Methods in Pharmaceuticals (3 papers). The work is most often cited by research in Immunology and Allergy (119 citations), Physiology (355 citations) and Rheumatology (185 citations). J. A. Steiner has collaborated with scholars based in United Kingdom, Switzerland and Australia. Frequent co-authors include Roy Pettipher, Mark A. Payton, L. Pearce Collins, Michael Hunter, Toby C. Lewis, Christopher Perkins, W. J. Jenkins, John I. Bell, A. David Smith and А. Г. Чучалин. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and Psychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact